Better healthcare, improved quality of life, containable costs
Our purpose is to enable a proper balance between good healthcare, great quality of life, and manageable costs. We can’t do this by ourselves. We empower everyone who receives, provides or manages healthcare, to make well-informed decisions. How? By giving them timely access to meaningful information.
We drive continuous and sustainable healthcare improvement. We assist…
Providers
Providers and provider associations in cure, care and dental health understand the impact of treatments on patients/clients, clinical outcomes and costs compared to peers.
Payers
Payers understand where and how they can get the value for money. Research shows that good outcomes and containable costs correlate.
Healthcare consumers
Consumers and consumer advocates understand that providers actively consider their needs and preferences. We empower meaningful freedom of choice.
Governments
Governments manage healthcare accessibility, quality and expenditure.
Life sciences & research institutes
Life science firms and research institutes get access to valid, relevant, trustworthy information from real-life data, whilst complying to privacy & security regulations.
Explore our solutions
Data-driven healthcare offers many opportunities. We collect and process data to report meaningful information on healthcare quality, processes and costs. You can use this to benchmark with peers, monitor patients and clients, or confer with patients to enable true shared decision making.
ValueBase
The most insightful all-in-one solution to practice value-based healthcare.
Would you like to focus on specific domains first?
How can we assist you?
Decision Support Solutions
Information for better individual decision making (for patients)
Consumer Outcomes & Experiences
Involving patients and clients
Health Economics & Costs
Value for money
Clinical Registries
Clinical performance indicators and studies
Consumer Services
Services to increase patient and client experiences
Advisory
Further support and analytics
Blog & news
15 November 2018
LOGEX lanceert in samenwerking met Prismant de Marktmonitor
LOGEX lanceert in samenwerking met Prismant de Marktmonitor: Groei en krimp verklaard vanuit regionale ontwikkelingen & marktaandeel.Gebruiksvriendelijk, actueel en herkenbaar: met de Marktmonitor zijn hoofdlijnen snel in beeld en kunnen financials en marketeers snel en eenvoudig inzoomen op relevante details.Als onderdeel van het Portfolio Analytics model is de LOGEX Marktmonitor gelanceerd. Dit product is ontwikkeld in samenwerking met Prismant, dat sinds 2018 onderdeel is van LOGEX group. Het betreft een online applicatie die het ziekenhuis inzicht biedt in actuele markt(aandeel) ontwikkelingen, opbouw van de patiënt populatie en inzicht naar verzekeraar en verwijzer. De ervaringen van Prismant Marktproducten zijn gecombineerd met de brede LOGEX benchmark en de LOGEX Smart Hospital Grid® technologie om het meest complete en actuele inzicht in de lokale en regionale ontwikkelingen te bieden.
15 October 2018
LOGEX, Ivbar, and Prodacapo join forces to create a European market leader in advanced costing and quality analytics for healthcare
With the aim of strengthening their ability to inform and support sustainable quality improvements, transparency and efficiency in healthcare LOGEX, Ivbar, and Prodacapo have decided to join forces through the new LOGEX Group, of which Value2Health is also part. This will create a European market leader in advanced software for analysing outcomes and costs in healthcare.Today, the three companies all hold leading positions in their respective markets – the Netherlands, Sweden, Finland, Norway, UK and France. The new LOGEX Group will have unmatched capacities to support a holistic approach to improvement in healthcare through advanced analytics. It brings together leading capabilities from quality and costing analytics.LOGEX is headquartered in Amsterdam and the pacesetter in the Dutch market for costing analytics, providing advanced solutions for cost tracking, budgeting and planning in healthcare. LOGEX is combined with Value2Health and MRDM. Value2Health, being the Dutch market leader in healthcare quality analytics, specializes in giving healthcare providers, receivers or organisers, access to reliable information making it possible to improve quality and outcomes. MRDM is expert in the field of data security and privacy.Ivbar is headquartered in Stockholm and is a market leader in Sweden in providing technical solutions for efficiency analytics and management of advanced payment models. Its mission is to support healthcare organisations to sustainably improve outcomes.Prodacapo is headquartered in Helsinki and is the market leader in Finland, Sweden and Norway in costing analytics for the healthcare sector. Prodacapo also has a strong presence in the UK market.The new LOGEX Group will create a favourable environment to allow for the companies to develop their core competencies and product portfolio further, with the aim of providing even stronger solutions to all stakeholders in the healthcare system, including providers, payers and authorities.“As we create a larger international group, customers will benefit from a more versatile product portfolio that meets a broader spectrum of their needs as they strive to drive improvements in their operations. Utilizing our tools to drive transparency and understanding of outcomes, resource use and costs in healthcare, will help our customers in their development, and ultimately benefit patients and society,” says Philipp Jan Flach, CEO of LOGEX Group.As healthcare expenditure constitutes a growing share of GDP in many European markets and healthcare budgets are under pressure, the demand for tools to improve efficiency and understand patient outcomes increases. The enlarged group will offer a holistic product offering, with strong potential to address these challenges.“Being able to provide our customers with deep insights on patient outcomes as well as costs and resources used in healthcare is unique, and extraordinarily important if we are to solve the challenges posed to our healthcare systems today,” says Kari Lappalainen, CEO of Prodacapo.LOGEX Group will be headquartered in Amsterdam with offices across Sweden, Finland, Norway, UK, France, Czech Republic and other locations in the Netherlands. This scope of operations provides the group a broad perspective on healthcare systems in Europe.“Broadening our geographical footprint, becoming a truly European company will create unmatched opportunities to benchmark healthcare performance across markets, regions and patient groups. This will provide invaluable insight for all stakeholders with an interest to improve healthcare,” says Jonas Wohlin, CEO of IVBAR.The new LOGEX Group will have more than 250 employees. Phillipp Jan Flach will be CEO of the new group.